About Abogen Biosciences
Abogen Biosciences is a company based in Suzhou (China) founded in 2019 by Dr InBev and Ying Bo.. Abogen Biosciences has raised $1.13 billion across 5 funding rounds from investors including Mirae Asset, Legend Holdings and Temasek. Abogen Biosciences operates in a competitive market with competitors including Moderna, Biological E, Vir Biotechnology, Vaxcyte and Cidara Therapeutics, among others.
- Headquarter Suzhou, China
- Founders Dr InBev, Ying Bo
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$1.13 B (USD)
in 5 rounds
-
Latest Funding Round
-
Investors
Mirae Asset
& 39 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Abogen Biosciences
Abogen Biosciences has successfully raised a total of $1.13B across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Last Round
-
First Round
First Round
(05 Nov 2020)
- Investors Count 40
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2022 | Amount | Series C - Abogen Biosciences | Valuation |
investors |
|
| Nov, 2021 | Amount | Series C - Abogen Biosciences | Valuation | SoftBank Vision Fund , 5Y Capital | |
| Aug, 2021 | Amount | Series C - Abogen Biosciences | Valuation | Temasek , GL Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Abogen Biosciences
Abogen Biosciences has secured backing from 40 investors, including institutional and venture fund investors. Prominent investors backing the company include Mirae Asset, Legend Holdings and Temasek. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments in technology and startups.
|
Founded Year | Domain | Location | |
|
A venture capital firm focused on technology and innovation investments.
|
Founded Year | Domain | Location | |
|
A private investment firm focused on regional opportunities.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Abogen Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Abogen Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Abogen Biosciences Comparisons
Competitors of Abogen Biosciences
Abogen Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Biological E, Vir Biotechnology, Vaxcyte and Cidara Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Vaccines and therapeutics for multiple diseases are developed and marketed.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of infectious diseases
|
|
| domain | founded_year | HQ Location |
Vaccines for infectious diseases are developed using cell-free protein synthesis.
|
|
| domain | founded_year | HQ Location |
Novel anti-infectives for bacterial and fungal infections are developed.
|
|
| domain | founded_year | HQ Location |
mRNA therapeutics platform is provided for multi-functional treatments.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Abogen Biosciences
Frequently Asked Questions about Abogen Biosciences
When was Abogen Biosciences founded?
Abogen Biosciences was founded in 2019 and raised its 1st funding round 1 year after it was founded.
Where is Abogen Biosciences located?
Abogen Biosciences is headquartered in Suzhou, China. It is registered at Suzhou, Jiangsu, China.
Who is the current CEO of Abogen Biosciences?
Dr InBev is the current CEO of Abogen Biosciences. They have also founded this company.
Is Abogen Biosciences a funded company?
Abogen Biosciences is a funded company, having raised a total of $1.13B across 5 funding rounds to date. The company's 1st funding round was a Series C of $720M, raised on Nov 05, 2020.
What does Abogen Biosciences do?
Abogen Biosciences was founded in 2019 in Suzhou, China, within the biotechnology sector. mRNA-based therapeutics are developed for cancer and infectious diseases. Proprietary technology platforms are employed in mRNA design, in vitro synthesis, and LNP-based delivery systems. Targeted therapies are created for infectious diseases and immuno-oncology indications through these operations.
Who are the top competitors of Abogen Biosciences?
Abogen Biosciences's top competitors include Moderna, Strand Therapeutics and Vaxcyte.
Who are Abogen Biosciences's investors?
Abogen Biosciences has 40 investors. Key investors include Mirae Asset, Legend Holdings, Temasek, Qiming Venture Partners, and SoftBank Vision Fund.